Cagri + Sema Blend
A co-formulated blend of cagrilintide and semaglutide studied for dual amylin and GLP-1 receptor engagement in metabolic research. Preclinical models investigate synergistic satiety signaling, weight-loss magnitude, and glucoregulatory effects beyond monotherapy.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
CS10
Peptide5mg+5mg × 10 vials (kit)
$200
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord